Literature DB >> 27668887

Achieving protection against HBV in HIV patients: Finding the best strategy.

Jose Ignacio Vargas1,2, Juan Pablo Arab1,3, Daniela Jensen4, Francisco Fuster2.   

Abstract

HBV and HIV coinfection is common and entails important morbi-mortality. Vaccination and anti-HBs seroconvertion is a desirable goal in HIV infected patients. New strategies are necessary to predict seroconversion and clinical endpoints. More studies, in the subgroup of HIV patients with poor immunovirological status are needed.

Entities:  

Keywords:  HBV; HIV; hepatitis; immunization; vaccine

Mesh：

Year:  2016        PMID： 27668887      PMCID： PMC5215422          DOI： 10.1080/21645515.2016.1215394

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  17 in total

1.  Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons.

Authors:  L Ryom; C Boesecke; V Gisler; C Manzardo; J K Rockstroh; M Puoti; H Furrer; J M Miro; J M Gatell; A Pozniak; G Behrens; M Battegay; J D Lundgren
Journal:  HIV Med       Date:  2015-11-08       Impact factor: 3.180

2.  Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.

Authors:  Mongkol Lao-Araya; Thanyawee Puthanakit; Linda Aurpibul; Sineenart Taecharoenkul; Thira Sirisanthana; Virat Sirisanthana
Journal:  Vaccine       Date:  2011-04-05       Impact factor: 3.641

3.  Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older--United States, 2013.

Authors: 
Journal:  MMWR Suppl       Date:  2013-02-01

4.  Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.

Authors:  Jose Ignacio Vargas; Daniela Jensen; Valeska Sarmiento; Felipe Peirano; Pedro Acuña; Felipe Fuster; Sabrina Soto; Rodrigo Ahumada; Marco Huilcaman; Mario Bruna; Werner Jensen; Francisco Fuster
Journal:  J Med Virol       Date:  2015-09-28       Impact factor: 2.327

5.  Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.

Authors:  Laura Sticchi; Bianca Bruzzone; Patrizia Caligiuri; Emanuela Rappazzo; Michele Lo Casto; Laura De Hoffer; Giulia Gustinetti; Claudio Viscoli; Antonio Di Biagio
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

6.  Hepatitis B and human immunodeficiency virus coinfection.

Authors:  Chloe L Thio
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

Authors:  Chloe L Thio; Eric C Seaberg; Richard Skolasky; John Phair; Barbara Visscher; Alvaro Muñoz; David L Thomas
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

8.  CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.

Authors:  Francisco Fuster; Jose Ignacio Vargas; Daniela Jensen; Valeska Sarmiento; Pedro Acuña; Felipe Peirano; Felipe Fuster; Juan Pablo Arab; Felipe Martínez
Journal:  Vaccine       Date:  2016-03-02       Impact factor: 3.641

9.  Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

Authors:  Michael G Bruce; Dana Bruden; Debby Hurlburt; Carolyn Zanis; Gail Thompson; Lisa Rea; Michele Toomey; Lisa Townshend-Bulson; Karen Rudolph; Lisa Bulkow; Philip R Spradling; Richard Baum; Thomas Hennessy; Brian J McMahon
Journal:  J Infect Dis       Date:  2016-01-21       Impact factor: 5.226

10.  British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

Authors:  Ed Wilkins; Mark Nelson; Kosh Agarwal; Dola Awoyemi; Eleanor Barnes; Sanjay Bhagani; Gary Brook; Ashley Brown; Sheena Castelino; Graham Cooke; Martin Fisher; Anna Maria Geretti; Robert James; Ranjababu Kulasegaram; Clifford Leen; David Mutimer; Chloe Orkin; Emma Page; Adrian Palfreeman; Padmasayee Papineni; Alison Rodger; C Y William Tong
Journal:  HIV Med       Date:  2013-11       Impact factor: 3.180
View more
  1 in total

1.  Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.

Authors:  Jose Ignacio Vargas; Daniela Jensen; Felipe Martínez; Valeska Sarmiento; Felipe Peirano; Pedro Acuña; Felipe Provoste; Valentina Bustos; Francisca Cornejo; Antonieta Fuster; Martin Acuña; Felipe Fuster; Sabrina Soto; Denisse Estay; Werner Jensen; Rodrigo Ahumada; Juan Pablo Arab; Alejandro Soza; Francisco Fuster
Journal:  JAMA Netw Open       Date:  2021-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.